Eckert & Ziegler SE Eckert & Ziegler SE

Eckert & Ziegler SE

EUZ

Rank in Stocks #8799
Eckert & Ziegler SE manufactures and sells isotope technology components in... Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Share Price
$15.52
Last synced: 2026-11-09
Market Cap
$971.25M
Change (1 day)
0.89%
Change (1 year)
-13.01%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Eckert & Ziegler SE (EUZ)
Operating Margin as of November 2026 TTM: 24.09%
According to Eckert & Ziegler SE's latest financial reports, its current operating margin (TTM) is 24.09%. At the end of 2025 the company had an operating margin of 24.06%.
Operating Margin history for Eckert & Ziegler SE from 2002 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 24.09% 0.12%
2025 24.06% 16.57%
2024 20.64% 8.06%
2023 19.10% -9.61%
2022 21.13% -17.17%
2021 25.51% 27.49%
2020 20.01% 12.92%
2019 17.72% 28.97%
2018 13.74% -0.72%
2017 13.84% 25.25%
2016 11.05% -12.58%
2015 12.64% 30.58%
2014 9.68% -12.08%
2013 11.01% -33.71%
2012 16.61% -15.51%
2011 19.66% 19.22%
2010 16.49% 8.13%
2009 15.25% 15.36%
2008 13.22% 20.51%
2007 10.97% -6.00%
2006 11.67% 92.26%
2005 6.07% -37.49%
2004 9.71% -24.02%
2003 12.78% 100.31%
2002 6.38% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.91% -99.22%
IE
10.95% -99.55%
CN
25.26% -98.95%
CH
13.54% -99.44%
CH
38.62% -98.40%
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Eckert & Ziegler SE's operating margin

What is Eckert & Ziegler SE's operating margin?

Eckert & Ziegler SE's operating margin is 24.09%, as of Nov 2026.

What was Eckert & Ziegler SE's operating margin in 2025?

In 2025, Eckert & Ziegler SE's operating margin was 24.06%, compared with 20.64% in 2024.

How has Eckert & Ziegler SE's operating margin changed since 2020?

From 2020 to 2025, Eckert & Ziegler SE's operating margin was highest in 2021 (25.51%) and lowest in 2023 (19.10%).

How does Eckert & Ziegler SE's operating margin compare with similar companies?

Eckert & Ziegler SE's operating margin (24.09%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.